The ABCs of IMHA: How to raise the PCV ASAP

Haematology, Internal Medicine

Immune Mediate Haemolytic Anaemia (IMHA) is the commonest haematologic condition encountered in small animal practice. Survival rates have been variably reported from 40-85% with many treatment options described. This session aims to review the treatment of IMHA and provide a rational approach to choosing the best treatment for individual patients.

• Correct diagnosis of IMHA
• Appropriate selection of immunosuppressive medication for cats and dogs with IMHA
• Appropriate selection of anti-thrombotic medication for dogs with IMHA
• Recognising the need for adjunctive treatment of cats and dogs with IMHA
• Long germ medication adjustment in IMHA

Chairperson - Lara Wilson, Regional Clinical Lead - CVS group ltd

Speaker - Mayank Seth, Clinical Director - Stansted Veterinary Specialists

Clinical Theatre 1
Thursday, 7 June, 14:55-15:45
Presented at BVA Live 2024
Please note this session is not RACE-approved but you can still earn a CPD certificate